APO Research
Talk to an analyst

APO RESEARCH · REPORT

Enoxaparin Sodium Injection

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Enoxaparin Sodium Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

20 December 2025193 pages

Choose your research edition.

Industry ResearchEnoxaparin Sodium Injection Industry Research Report 2026136 pages · $2,950 USDIndustry Growth & TrendsGlobal Enoxaparin Sodium Injection Industry Growth and Trends Forecast to 2032118 pages · $3,450 USDMarket StructureGlobal Enoxaparin Sodium Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Enoxaparin Sodium Injection Market Outlook and Growth Opportunities 2026204 pages · $4,250 USDMarket Analysis & ForecastGlobal Enoxaparin Sodium Injection Market Analysis and Forecast 2026-2032203 pages · $4,950 USD

Market perspective

The global Enoxaparin Sodium Injection market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Enoxaparin Sodium Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Enoxaparin Sodium Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Enoxaparin Sodium Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Enoxaparin Sodium Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Enoxaparin Sodium Injection include Teva, Suzhou Erye Pharmaceutical, Sandoz, Sanofi, Nanjing King-friend, Hangzhou Jiuyuan Gene Engineering, Hebei Changshan Biochemical Pharmaceutical, Fresenius Kabi and Changzhou Qianhong Bio-pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Enoxaparin Sodium Injection market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Enoxaparin Sodium Injection and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Enoxaparin Sodium Injection sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Enoxaparin Sodium Injection market size, projected growth trends, production technologies, key applications, and end-use industries.

Enoxaparin Sodium Injection Segment by Company

Teva

Suzhou Erye Pharmaceutical

Sandoz

Sanofi

Nanjing King-friend

Hangzhou Jiuyuan Gene Engineering

Hebei Changshan Biochemical Pharmaceutical

Fresenius Kabi

Changzhou Qianhong Bio-pharma

Beijing SL Pharmaceutical

Chengdu Baiyu Pharmaceutical

Techdow (Hepalink)

Taj Pharma

Rovi

Cipla

Apotex

Amphastar

Enoxaparin Sodium Injection Segment by Type

100 mg/1mL

120 mg/0.8mL

150 mg/1mL

20 mg/0.2mL

30 mg/0.3mL

300mg/3mL

40 mg/0.4mL

60 mg/0.6mL

80 mg/0.8mL

Enoxaparin Sodium Injection Segment by Application

Hospital

Clinic

Others

Enoxaparin Sodium Injection Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Enoxaparin Sodium Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Enoxaparin Sodium Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Enoxaparin Sodium Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Enoxaparin Sodium Injection market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Enoxaparin Sodium Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Enoxaparin Sodium Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Enoxaparin Sodium Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Enoxaparin Sodium Injection Industry Trends Table 2. Enoxaparin Sodium Injection Industry Drivers Table 3. Enoxaparin Sodium Injection Industry Opportunities and Challenges Table 4. Enoxaparin Sodium Injection Industry Restraints Table 5. Global Enoxaparin Sodium Injection Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Enoxaparin Sodium Injection Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Enoxaparin Sodium Injection Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Enoxaparin Sodium Injection Sales Market Share by Manufacturers Table 9. Global Enoxaparin Sodium Injection Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Enoxaparin Sodium Injection Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Enoxaparin Sodium Injection Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Enoxaparin Sodium Injection Manufacturers, Product Type & Application Table 13. Global Enoxaparin Sodium Injection Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Enoxaparin Sodium Injection by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 100 mg/1mL Table 17. Major Manufacturers of 120 mg/0.8mL Table 18. Major Manufacturers of 150 mg/1mL Table 19. Major Manufacturers of 20 mg/0.2mL Table 20. Major Manufacturers of 30 mg/0.3mL Table 21. Major Manufacturers of 300mg/3mL Table 22. Major Manufacturers of 40 mg/0.4mL Table 23. Major Manufacturers of 60 mg/0.6mL Table 24. Major Manufacturers of 80 mg/0.8mL Table 25. Global Enoxaparin Sodium Injection Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 26. Global Enoxaparin Sodium Injection Sales by Type (2021-2026) & (K Units) Table 27. Global Enoxaparin Sodium Injection Sales by Type (2027-2032) & (K Units) Table 28. Global Enoxaparin Sodium Injection Sales Market Share by Type (2021-2026) Table 29. Global Enoxaparin Sodium Injection Sales Market Share by Type (2027-2032) Table 30. Global Enoxaparin Sodium Injection Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 31. Global Enoxaparin Sodium Injection Revenue by Type (2021-2026) & (K Units) Table 32. Global Enoxaparin Sodium Injection Revenue by Type (2027-2032) & (K Units) Table 33. Global Enoxaparin Sodium Injection Revenue Market Share by Type (2021-2026) Table 34. Global Enoxaparin Sodium Injection Revenue Market Share by Type (2027-2032) Table 35. Major Manufacturers of Hospital Table 36. Major Manufacturers of Clinic Table 37. Major Manufacturers of Others Table 38. Global Enoxaparin Sodium Injection Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 39. Global Enoxaparin Sodium Injection Sales by Application (2021-2026) & (K Units) Table 40. Global Enoxaparin Sodium Injection Sales by Application (2027-2032) & (K Units) Table 41. Global Enoxaparin Sodium Injection Sales Market Share by Application (2021-2026) Table 42. Global Enoxaparin Sodium Injection Sales Market Share by Application (2027-2032) Table 43. Global Enoxaparin Sodium Injection Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 44. Global Enoxaparin Sodium Injection Revenue by Application (2021-2026) & (K Units) Table 45. Global Enoxaparin Sodium Injection Revenue by Application (2027-2032) & (K Units) Table 46. Global Enoxaparin Sodium Injection Revenue Market Share by Application (2021-2026) Table 47. Global Enoxaparin Sodium Injection Revenue Market Share by Application (2027-2032) Table 48. Global Enoxaparin Sodium Injection Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 49. Global Enoxaparin Sodium Injection Sales by Region (2021-2026) & (K Units) Table 50. Global Enoxaparin Sodium Injection Sales Market Share by Region (2021-2026) Table 51. Global Enoxaparin Sodium Injection Sales Forecasted by Region (2027-2032) & (K Units) Table 52. Global Enoxaparin Sodium Injection Sales Forecasted Market Share by Region (2027-2032) Table 53. North America Enoxaparin Sodium Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. North America Enoxaparin Sodium Injection Sales by Country (2021-2026) & (K Units) Table 55. North America Enoxaparin Sodium Injection Sales by Country (2027-2032) & (K Units) Table 56. Europe Enoxaparin Sodium Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. Europe Enoxaparin Sodium Injection Sales by Country (2021-2026) & (K Units) Table 58. Europe Enoxaparin Sodium Injection Sales by Country (2027-2032) & (K Units) Table 59. Asia Pacific Enoxaparin Sodium Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 60. Asia Pacific Enoxaparin Sodium Injection Sales by Country (2021-2026) & (K Units) Table 61. Asia Pacific Enoxaparin Sodium Injection Sales by Country (2027-2032) & (K Units) Table 62. South America, Middle East and Africa Enoxaparin Sodium Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 63. South America, Middle East and Africa Enoxaparin Sodium Injection Sales by Country (2021-2026) & (K Units) Table 64. South America, Middle East and Africa Enoxaparin Sodium Injection Sales by Country (2027-2032) & (K Units) Table 65. Global Enoxaparin Sodium Injection Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 66. Global Enoxaparin Sodium Injection Revenue by Region (2021-2026) & (US$ Million) Table 67. Global Enoxaparin Sodium Injection Revenue by Region (2027-2032) & (US$ Million) Table 68. Global Enoxaparin Sodium Injection Revenue Market Share by Region (2021-2026) Table 69. Global Enoxaparin Sodium Injection Revenue Market Share by Region (2027-2032) Table 70. Teva Company Information Table 71. Teva Business Overview Table 72. Teva Enoxaparin Sodium Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Teva Enoxaparin Sodium Injection Product Portfolio Table 74. Teva Recent Development Table 75. Suzhou Erye Pharmaceutical Company Information Table 76. Suzhou Erye Pharmaceutical Business Overview Table 77. Suzhou Erye Pharmaceutical Enoxaparin Sodium Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Suzhou Erye Pharmaceutical Enoxaparin Sodium Injection Product Portfolio Table 79. Suzhou Erye Pharmaceutical Recent Development Table 80. Sandoz Company Information Table 81. Sandoz Business Overview Table 82. Sandoz Enoxaparin Sodium Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Sandoz Enoxaparin Sodium Injection Product Portfolio Table 84. Sandoz Recent Development Table 85. Sanofi Company Information Table 86. Sanofi Business Overview Table 87. Sanofi Enoxaparin Sodium Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Sanofi Enoxaparin Sodium Injection Product Portfolio Table 89. Sanofi Recent Development Table 90. Nanjing King-friend Company Information Table 91. Nanjing King-friend Business Overview Table 92. Nanjing King-friend Enoxaparin Sodium Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. Nanjing King-friend Enoxaparin Sodium Injection Product Portfolio Table 94. Nanjing King-friend Recent Development Table 95. Hangzhou Jiuyuan Gene Engineering Company Information Table 96. Hangzhou Jiuyuan Gene Engineering Business Overview Table 97. Hangzhou Jiuyuan Gene Engineering Enoxaparin Sodium Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 98. Hangzhou Jiuyuan Gene Engineering Enoxaparin Sodium Injection Product Portfolio Table 99. Hangzhou Jiuyuan Gene Engineering Recent Development Table 100. Hebei Changshan Biochemical Pharmaceutical Company Information Table 101. Hebei Changshan Biochemical Pharmaceutical Business Overview Table 102. Hebei Changshan Biochemical Pharmaceutical Enoxaparin Sodium Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 103. Hebei Changshan Biochemical Pharmaceutical Enoxaparin Sodium Injection Product Portfolio Table 104. Hebei Changshan Biochemical Pharmaceutical Recent Development Table 105. Fresenius Kabi Company Information Table 106. Fresenius Kabi Business Overview Table 107. Fresenius Kabi Enoxaparin Sodium Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 108. Fresenius Kabi Enoxaparin Sodium Injection Product Portfolio Table 109. Fresenius Kabi Recent Development Table 110. Changzhou Qianhong Bio-pharma Company Information Table 111. Changzhou Qianhong Bio-pharma Business Overview Table 112. Changzhou Qianhong Bio-pharma Enoxaparin Sodium Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 113. Changzhou Qianhong Bio-pharma Enoxaparin Sodium Injection Product Portfolio Table 114. Changzhou Qianhong Bio-pharma Recent Development Table 115. Beijing SL Pharmaceutical Company Information Table 116. Beijing SL Pharmaceutical Business Overview Table 117. Beijing SL Pharmaceutical Enoxaparin Sodium Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 118. Beijing SL Pharmaceutical Enoxaparin Sodium Injection Product Portfolio Table 119. Beijing SL Pharmaceutical Recent Development Table 120. Chengdu Baiyu Pharmaceutical Company Information Table 121. Chengdu Baiyu Pharmaceutical Business Overview Table 122. Chengdu Baiyu Pharmaceutical Enoxaparin Sodium Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 123. Chengdu Baiyu Pharmaceutical Enoxaparin Sodium Injection Product Portfolio Table 124. Chengdu Baiyu Pharmaceutical Recent Development Table 125. Techdow (Hepalink) Company Information Table 126. Techdow (Hepalink) Business Overview Table 127. Techdow (Hepalink) Enoxaparin Sodium Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 128. Techdow (Hepalink) Enoxaparin Sodium Injection Product Portfolio Table 129. Techdow (Hepalink) Recent Development Table 130. Taj Pharma Company Information Table 131. Taj Pharma Business Overview Table 132. Taj Pharma Enoxaparin Sodium Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 133. Taj Pharma Enoxaparin Sodium Injection Product Portfolio Table 134. Taj Pharma Recent Development Table 135. Rovi Company Information Table 136. Rovi Business Overview Table 137. Rovi Enoxaparin Sodium Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 138. Rovi Enoxaparin Sodium Injection Product Portfolio Table 139. Rovi Recent Development Table 140. Cipla Company Information Table 141. Cipla Business Overview Table 142. Cipla Enoxaparin Sodium Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 143. Cipla Enoxaparin Sodium Injection Product Portfolio Table 144. Cipla Recent Development Table 145. Apotex Company Information Table 146. Apotex Business Overview Table 147. Apotex Enoxaparin Sodium Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 148. Apotex Enoxaparin Sodium Injection Product Portfolio Table 149. Apotex Recent Development Table 150. Amphastar Company Information Table 151. Amphastar Business Overview Table 152. Amphastar Enoxaparin Sodium Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 153. Amphastar Enoxaparin Sodium Injection Product Portfolio Table 154. Amphastar Recent Development Table 155. Key Raw Materials Table 156. Raw Materials Key Suppliers Table 157. Enoxaparin Sodium Injection Distributors List Table 158. Enoxaparin Sodium Injection Customers List Table 159. Research Programs/Design for This Report Table 160. Authors List of This Report Table 161. Secondary Sources Table 162. Primary Sources List of Figures Figure 1. Enoxaparin Sodium Injection Product Image Figure 2. Global Enoxaparin Sodium Injection Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Enoxaparin Sodium Injection Market Size (2021-2032) & (US$ Million) Figure 4. Global Enoxaparin Sodium Injection Sales (2021-2032) & (K Units) Figure 5. Global Enoxaparin Sodium Injection Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Enoxaparin Sodium Injection Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 100 mg/1mL Image Figure 9. 120 mg/0.8mL Image Figure 10. 150 mg/1mL Image Figure 11. 20 mg/0.2mL Image Figure 12. 30 mg/0.3mL Image Figure 13. 300mg/3mL Image Figure 14. 40 mg/0.4mL Image Figure 15. 60 mg/0.6mL Image Figure 16. 80 mg/0.8mL Image Figure 17. Global Enoxaparin Sodium Injection Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 18. Global Enoxaparin Sodium Injection Sales Market Share 2021 VS 2025 VS 2032 Figure 19. Global Enoxaparin Sodium Injection Sales Market Share by Type (2021-2032) Figure 20. Global Enoxaparin Sodium Injection Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Enoxaparin Sodium Injection Revenue Market Share 2021 VS 2025 VS 2032 Figure 22. Global Enoxaparin Sodium Injection Revenue Market Share by Type (2021-2032) Figure 23. Hospital Image Figure 24. Clinic Image Figure 25. Others Image Figure 26. Global Enoxaparin Sodium Injection Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 27. Global Enoxaparin Sodium Injection Sales Market Share 2021 VS 2025 VS 2032 Figure 28. Global Enoxaparin Sodium Injection Sales Market Share by Application (2021-2032) Figure 29. Global Enoxaparin Sodium Injection Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 30. Global Enoxaparin Sodium Injection Revenue Market Share 2021 VS 2025 VS 2032 Figure 31. Global Enoxaparin Sodium Injection Revenue Market Share by Application (2021-2032) Figure 32. North America Enoxaparin Sodium Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 33. North America Enoxaparin Sodium Injection Sales Market Share by Country (2021-2032) Figure 34. U.S. Enoxaparin Sodium Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Canada Enoxaparin Sodium Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Mexico Enoxaparin Sodium Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Europe Enoxaparin Sodium Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Europe Enoxaparin Sodium Injection Sales Market Share by Country (2021-2032) Figure 39. Germany Enoxaparin Sodium Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 40. France Enoxaparin Sodium Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 41. U.K. Enoxaparin Sodium Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Italy Enoxaparin Sodium Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Netherlands Enoxaparin Sodium Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Asia Pacific Enoxaparin Sodium Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Asia Pacific Enoxaparin Sodium Injection Sales Market Share by Country (2021-2032) Figure 46. China Enoxaparin Sodium Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 47. Japan Enoxaparin Sodium Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Korea Enoxaparin Sodium Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Southeast Asia Enoxaparin Sodium Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 50. India Enoxaparin Sodium Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Australia Enoxaparin Sodium Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 52. South America, Middle East and Africa Enoxaparin Sodium Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 53. South America, Middle East and Africa Enoxaparin Sodium Injection Sales Market Share by Country (2021-2032) Figure 54. Brazil Enoxaparin Sodium Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 55. South Africa Enoxaparin Sodium Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Saudi Arabia Enoxaparin Sodium Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Turkey Enoxaparin Sodium Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 58. Argentina Enoxaparin Sodium Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 59. UAE Enoxaparin Sodium Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 60. Egypt Enoxaparin Sodium Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 61. Chile Enoxaparin Sodium Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 62. Global Enoxaparin Sodium Injection Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 63. Global Enoxaparin Sodium Injection Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 64. North America Enoxaparin Sodium Injection Revenue (2021-2032) & (US$ Million) Figure 65. North America Enoxaparin Sodium Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Europe Enoxaparin Sodium Injection Revenue (2021-2032) & (US$ Million) Figure 67. Europe Enoxaparin Sodium Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. Asia-Pacific Enoxaparin Sodium Injection Revenue (2021-2032) & (US$ Million) Figure 69. Asia-Pacific Enoxaparin Sodium Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 70. South America, Middle East and Africa Enoxaparin Sodium Injection Revenue (2021-2032) & (US$ Million) Figure 71. South America, Middle East and Africa Enoxaparin Sodium Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 72. Enoxaparin Sodium Injection Value Chain Figure 73. Manufacturing Cost Structure Figure 74. Enoxaparin Sodium Injection Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Years Considered Figure 78. Research Process Figure 79. Key Executives Interviewed

Scope & coverage.

Types
  • 100 mg/1mL
  • 120 mg/0.8mL
  • 150 mg/1mL
  • 20 mg/0.2mL
  • 30 mg/0.3mL
  • 300mg/3mL
  • 40 mg/0.4mL
  • 60 mg/0.6mL
  • 80 mg/0.8mL
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Teva
  • Suzhou Erye Pharmaceutical
  • Sandoz
  • Sanofi
  • Nanjing King-friend
  • Hangzhou Jiuyuan Gene Engineering
  • Hebei Changshan Biochemical Pharmaceutical
  • Fresenius Kabi
  • Changzhou Qianhong Bio-pharma
  • Beijing SL Pharmaceutical
  • Chengdu Baiyu Pharmaceutical
  • Techdow (Hepalink)
  • Taj Pharma
  • Rovi
  • Cipla
  • Apotex
  • Amphastar

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Enoxaparin Sodium Injection Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Enoxaparin Sodium Injection Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Enoxaparin Sodium Injection Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Enoxaparin Sodium Injection Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Enoxaparin Sodium Injection Market Dynamics
  1. 2.1 Enoxaparin Sodium Injection Industry Trends
  2. 2.2 Enoxaparin Sodium Injection Industry Drivers
  3. 2.3 Enoxaparin Sodium Injection Industry Opportunities and Challenges
  4. 2.4 Enoxaparin Sodium Injection Industry Restraints
3 Enoxaparin Sodium Injection Market by Manufacturers
  1. 3.1 Global Enoxaparin Sodium Injection Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Enoxaparin Sodium Injection Sales by Manufacturers (2021-2026)
  3. 3.3 Global Enoxaparin Sodium Injection Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Enoxaparin Sodium Injection Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Enoxaparin Sodium Injection Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Enoxaparin Sodium Injection Manufacturers, Product Type & Application
  7. 3.7 Global Enoxaparin Sodium Injection Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Enoxaparin Sodium Injection Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Enoxaparin Sodium Injection Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Enoxaparin Sodium Injection Tier 1, Tier 2, and Tier 3
4 Enoxaparin Sodium Injection Market by Type
  1. 4.1 Enoxaparin Sodium Injection Type Introduction
  2. 4.1.1 100 mg/1mL
  3. 4.1.2 120 mg/0.8mL
  4. 4.1.3 150 mg/1mL
  5. 4.1.4 20 mg/0.2mL
  6. 4.1.5 30 mg/0.3mL
  7. 4.1.6 300mg/3mL
  8. 4.1.7 40 mg/0.4mL
  9. 4.1.8 60 mg/0.6mL
  10. 4.1.9 80 mg/0.8mL
  11. 4.2 Global Enoxaparin Sodium Injection Sales by Type
  12. 4.2.1 Global Enoxaparin Sodium Injection Sales by Type (2021 VS 2025 VS 2032)
  13. 4.2.2 Global Enoxaparin Sodium Injection Sales by Type (2021-2032)
  14. 4.2.3 Global Enoxaparin Sodium Injection Sales Market Share by Type (2021-2032)
  15. 4.3 Global Enoxaparin Sodium Injection Revenue by Type
  16. 4.3.1 Global Enoxaparin Sodium Injection Revenue by Type (2021 VS 2025 VS 2032)
  17. 4.3.2 Global Enoxaparin Sodium Injection Revenue by Type (2021-2032)
  18. 4.3.3 Global Enoxaparin Sodium Injection Revenue Market Share by Type (2021-2032)
5 Enoxaparin Sodium Injection Market by Application
  1. 5.1 Enoxaparin Sodium Injection Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Enoxaparin Sodium Injection Sales by Application
  6. 5.2.1 Global Enoxaparin Sodium Injection Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Enoxaparin Sodium Injection Sales by Application (2021-2032)
  8. 5.2.3 Global Enoxaparin Sodium Injection Sales Market Share by Application (2021-2032)
  9. 5.3 Global Enoxaparin Sodium Injection Revenue by Application
  10. 5.3.1 Global Enoxaparin Sodium Injection Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Enoxaparin Sodium Injection Revenue by Application (2021-2032)
  12. 5.3.3 Global Enoxaparin Sodium Injection Revenue Market Share by Application (2021-2032)
6 Global Enoxaparin Sodium Injection Sales by Region
  1. 6.1 Global Enoxaparin Sodium Injection Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Enoxaparin Sodium Injection Sales by Region (2021-2032)
  3. 6.2.1 Global Enoxaparin Sodium Injection Sales by Region (2021-2026)
  4. 6.2.2 Global Enoxaparin Sodium Injection Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Enoxaparin Sodium Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Enoxaparin Sodium Injection Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Enoxaparin Sodium Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Enoxaparin Sodium Injection Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Enoxaparin Sodium Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Enoxaparin Sodium Injection Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Enoxaparin Sodium Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Enoxaparin Sodium Injection Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Enoxaparin Sodium Injection Revenue by Region
  1. 7.1 Global Enoxaparin Sodium Injection Revenue by Region
  2. 7.1.1 Global Enoxaparin Sodium Injection Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Enoxaparin Sodium Injection Revenue by Region (2021-2026)
  4. 7.1.3 Global Enoxaparin Sodium Injection Revenue by Region (2027-2032)
  5. 7.1.4 Global Enoxaparin Sodium Injection Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Enoxaparin Sodium Injection Revenue (2021-2032)
  8. 7.2.2 North America Enoxaparin Sodium Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Enoxaparin Sodium Injection Revenue (2021-2032)
  11. 7.3.2 Europe Enoxaparin Sodium Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Enoxaparin Sodium Injection Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Enoxaparin Sodium Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Enoxaparin Sodium Injection Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Enoxaparin Sodium Injection Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Teva
  2. 8.1.1 Teva Company Information
  3. 8.1.2 Teva Business Overview
  4. 8.1.3 Teva Enoxaparin Sodium Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Teva Enoxaparin Sodium Injection Product Portfolio
  6. 8.1.5 Teva Recent Developments
  7. 8.2 Suzhou Erye Pharmaceutical
  8. 8.2.1 Suzhou Erye Pharmaceutical Company Information
  9. 8.2.2 Suzhou Erye Pharmaceutical Business Overview
  10. 8.2.3 Suzhou Erye Pharmaceutical Enoxaparin Sodium Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Suzhou Erye Pharmaceutical Enoxaparin Sodium Injection Product Portfolio
  12. 8.2.5 Suzhou Erye Pharmaceutical Recent Developments
  13. 8.3 Sandoz
  14. 8.3.1 Sandoz Company Information
  15. 8.3.2 Sandoz Business Overview
  16. 8.3.3 Sandoz Enoxaparin Sodium Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Sandoz Enoxaparin Sodium Injection Product Portfolio
  18. 8.3.5 Sandoz Recent Developments
  19. 8.4 Sanofi
  20. 8.4.1 Sanofi Company Information
  21. 8.4.2 Sanofi Business Overview
  22. 8.4.3 Sanofi Enoxaparin Sodium Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Sanofi Enoxaparin Sodium Injection Product Portfolio
  24. 8.4.5 Sanofi Recent Developments
  25. 8.5 Nanjing King-friend
  26. 8.5.1 Nanjing King-friend Company Information
  27. 8.5.2 Nanjing King-friend Business Overview
  28. 8.5.3 Nanjing King-friend Enoxaparin Sodium Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Nanjing King-friend Enoxaparin Sodium Injection Product Portfolio
  30. 8.5.5 Nanjing King-friend Recent Developments
  31. 8.6 Hangzhou Jiuyuan Gene Engineering
  32. 8.6.1 Hangzhou Jiuyuan Gene Engineering Company Information
  33. 8.6.2 Hangzhou Jiuyuan Gene Engineering Business Overview
  34. 8.6.3 Hangzhou Jiuyuan Gene Engineering Enoxaparin Sodium Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Hangzhou Jiuyuan Gene Engineering Enoxaparin Sodium Injection Product Portfolio
  36. 8.6.5 Hangzhou Jiuyuan Gene Engineering Recent Developments
  37. 8.7 Hebei Changshan Biochemical Pharmaceutical
  38. 8.7.1 Hebei Changshan Biochemical Pharmaceutical Company Information
  39. 8.7.2 Hebei Changshan Biochemical Pharmaceutical Business Overview
  40. 8.7.3 Hebei Changshan Biochemical Pharmaceutical Enoxaparin Sodium Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Hebei Changshan Biochemical Pharmaceutical Enoxaparin Sodium Injection Product Portfolio
  42. 8.7.5 Hebei Changshan Biochemical Pharmaceutical Recent Developments
  43. 8.8 Fresenius Kabi
  44. 8.8.1 Fresenius Kabi Company Information
  45. 8.8.2 Fresenius Kabi Business Overview
  46. 8.8.3 Fresenius Kabi Enoxaparin Sodium Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Fresenius Kabi Enoxaparin Sodium Injection Product Portfolio
  48. 8.8.5 Fresenius Kabi Recent Developments
  49. 8.9 Changzhou Qianhong Bio-pharma
  50. 8.9.1 Changzhou Qianhong Bio-pharma Company Information
  51. 8.9.2 Changzhou Qianhong Bio-pharma Business Overview
  52. 8.9.3 Changzhou Qianhong Bio-pharma Enoxaparin Sodium Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Changzhou Qianhong Bio-pharma Enoxaparin Sodium Injection Product Portfolio
  54. 8.9.5 Changzhou Qianhong Bio-pharma Recent Developments
  55. 8.10 Beijing SL Pharmaceutical
  56. 8.10.1 Beijing SL Pharmaceutical Company Information
  57. 8.10.2 Beijing SL Pharmaceutical Business Overview
  58. 8.10.3 Beijing SL Pharmaceutical Enoxaparin Sodium Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Beijing SL Pharmaceutical Enoxaparin Sodium Injection Product Portfolio
  60. 8.10.5 Beijing SL Pharmaceutical Recent Developments
  61. 8.11 Chengdu Baiyu Pharmaceutical
  62. 8.11.1 Chengdu Baiyu Pharmaceutical Company Information
  63. 8.11.2 Chengdu Baiyu Pharmaceutical Business Overview
  64. 8.11.3 Chengdu Baiyu Pharmaceutical Enoxaparin Sodium Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Chengdu Baiyu Pharmaceutical Enoxaparin Sodium Injection Product Portfolio
  66. 8.11.5 Chengdu Baiyu Pharmaceutical Recent Developments
  67. 8.12 Techdow (Hepalink)
  68. 8.12.1 Techdow (Hepalink) Company Information
  69. 8.12.2 Techdow (Hepalink) Business Overview
  70. 8.12.3 Techdow (Hepalink) Enoxaparin Sodium Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Techdow (Hepalink) Enoxaparin Sodium Injection Product Portfolio
  72. 8.12.5 Techdow (Hepalink) Recent Developments
  73. 8.13 Taj Pharma
  74. 8.13.1 Taj Pharma Company Information
  75. 8.13.2 Taj Pharma Business Overview
  76. 8.13.3 Taj Pharma Enoxaparin Sodium Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Taj Pharma Enoxaparin Sodium Injection Product Portfolio
  78. 8.13.5 Taj Pharma Recent Developments
  79. 8.14 Rovi
  80. 8.14.1 Rovi Company Information
  81. 8.14.2 Rovi Business Overview
  82. 8.14.3 Rovi Enoxaparin Sodium Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Rovi Enoxaparin Sodium Injection Product Portfolio
  84. 8.14.5 Rovi Recent Developments
  85. 8.15 Cipla
  86. 8.15.1 Cipla Company Information
  87. 8.15.2 Cipla Business Overview
  88. 8.15.3 Cipla Enoxaparin Sodium Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Cipla Enoxaparin Sodium Injection Product Portfolio
  90. 8.15.5 Cipla Recent Developments
  91. 8.16 Apotex
  92. 8.16.1 Apotex Company Information
  93. 8.16.2 Apotex Business Overview
  94. 8.16.3 Apotex Enoxaparin Sodium Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Apotex Enoxaparin Sodium Injection Product Portfolio
  96. 8.16.5 Apotex Recent Developments
  97. 8.17 Amphastar
  98. 8.17.1 Amphastar Company Information
  99. 8.17.2 Amphastar Business Overview
  100. 8.17.3 Amphastar Enoxaparin Sodium Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Amphastar Enoxaparin Sodium Injection Product Portfolio
  102. 8.17.5 Amphastar Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Enoxaparin Sodium Injection Value Chain Analysis
  2. 9.1.1 Enoxaparin Sodium Injection Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Enoxaparin Sodium Injection Production Mode & Process
  6. 9.2 Enoxaparin Sodium Injection Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Enoxaparin Sodium Injection Distributors
  9. 9.2.3 Enoxaparin Sodium Injection Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst